Merrimack
Merrimack (NASDAQ: MACK) is a Cambridge, Massachusetts-based biopharmaceutical company founded in 2000 that designs and develops oncology medicines. Operating with 51-100 employees, the firm is in a corporate wind-down phase.
- Company typePrivate
- Founded2000
- HeadquartersCambridge, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Merrimack does
Merrimack (NASDAQ: MACK) is a Cambridge, Massachusetts-based biopharmaceutical company founded in 2000 that designs and develops medicines to treat cancer. Operating with a current headcount of 51–100 employees, the firm has historically pursued oncology therapeutics through research, clinical development, and commercialization functions typical of a small-cap biotech, and maintains a public listing on NASDAQ under the ticker MACK.
Over its operating history, Merrimack has raised approximately $429 million across more than 15 funding rounds between 2002 and 2018, drawing capital from a mix of venture investors, crossover funds, and debt providers including Hercules Capital, Credit Suisse, Crocker Ventures, Jennison Associates, TPG-Axon Capital, and WT Investment Advisors Fund. Hercules Capital served as a repeated capital partner, appearing as lead investor in the 2005 and 2018 rounds.
The company's current operating profile is characterized by sustained leadership under CEO Gary Crocker alongside William A. Sullivan (Head of Finance and Accounting) and William M. McClements (Head of Corporate Operations); absence of disclosed revenue for fiscal years 2021–2023; and reported operating losses in prior periods. The combination of a lean headcount, no disclosed top-line, and no capital raises since July 2018 is consistent with a post-transaction or wind-down phase rather than active commercial expansion. Note: a substantial portion of the aggregated input data describes Merrimack Group, a separate investment banking entity; this description reflects the biopharmaceutical firm identified in the firmographic header.
Merrimack firmographics
Firmographics- Name
- Merrimack
- Legal name
- Merrimack Group, LLC
- Website
- https://merrimack.com
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Merrimack (NASDAQ: MACK) is a Cambridge, Massachusetts-based biopharmaceutical company founded in 2000 that designs and develops oncology medicines. Operating with 51-100 employees, the firm is in a corporate wind-down phase.
- Ownership category
- akta.pro rank
Where Merrimack is headquartered
LocationHeadquarters
- HQ city
- Cambridge
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Merrimack business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- M&A Advisory Fees: Merrimack Group provides sell-side mergers and acquisitions advisory services to technical product companies. The firm earns fees for managing the sale process, conducting competitive processes to generate multiple offers, and ultimately closing transactions. Revenue is generated through transaction-based advisory fees tied to deal completion.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom M&A advisory engagement pricing |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Merrimack product offering
Product offeringCore offering
Merrimack Group is a specialist investment bank that provides sell-side mergers and acquisitions advisory services to founder-owned and privately held technical product companies. The firm manages the entire sale process from preparation through closing, including business positioning, buyer identification, competitive process management, and negotiation, targeting businesses with $20M-$200M in revenue. Merrimack has completed more than 30 transactions representing over $1 billion in aggregate enterprise value across lighting, aerospace & defense, electrical equipment, metal fabrication, industrial automation, and biotechnology sectors.
Product overview
Merrimack Group is a specialist investment bank providing sell-side mergers and acquisitions advisory services exclusively. The firm does not offer a software platform or modular product architecture; instead, it delivers professional advisory services as its core offering. The company's services span the full M&A transaction lifecycle, including business positioning, buyer outreach, negotiation support, and transaction closing. Merrimack Group serves technical product companies with $20M–$200M in revenue across several industry verticals including Lighting, Aerospace & Defense, Electrical Equipment, Metal Fabrication, Industrial Automation, and Biotechnology. The firm has completed over 30 transactions representing over $1 billion in aggregate deal value.
Differentiator
Problem solved
Functional benefit
Products and services
- Sell-Side M&A Advisory Services
Quantifiable outcome
- More than 30 completed transactions representing over $1 billion in enterprise value
- +2 more outcomes
Companies that use Merrimack
Customer profileNamed customers15 records
Segments5 records
Ideal customer profiles2 records
Merrimack technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Merrimack partnerships and signals
Strategic signalScale indicators5 records
Recent moves5 records
Merrimack competitors and assessment
Company assessmentDirect peers
- Cascade Partners: Cascade Partners is a boutique investment bank specializing in middle-market M&A advisory across industrial, consumer, and technology sectors. It is one of the closest direct competitors to Merrimack Group given its similar focus on engineered/technical product companies and middle-market sell-side mandates.
- TravisWolff: TravisWolff is a boutique advisory firm with deep specialization in the lighting industry, providing M&A and strategic advisory to lighting manufacturers and suppliers. It directly competes with Merrimack Group's lighting vertical and serves a similar mid-market, founder-owned client base.
- Lincoln International: Lincoln International is a global mid-market investment bank with strong industrials and technology coverage, frequently advising on cross-border technical product company transactions. It competes with Merrimack Group on mid-market sell-side mandates, particularly for larger industrial and aerospace & defense opportunities.
- Livingstone Partners: Livingstone Partners is a mid-market M&A advisor with dedicated industrial, business services, and consumer practices. It directly overlaps with Merrimack Group's focus on technical product and industrial manufacturing sell-side mandates in the same revenue range.
- Cascadia Capital: Cascadia Capital is a middle-market investment bank focused on industries including industrial technology, aerospace & defense, and consumer products. It is a direct peer to Merrimack Group given its overlapping verticals and similar mid-market, founder/PE-backed client base.
- PMCF (Plante Moran Corporate Finance): PMCF provides M&A advisory services to middle-market industrial businesses, with strong coverage of specialty manufacturing and technical product companies. It is a direct competitor to Merrimack Group in industrial/technical product sell-side mandates.
- Brown Gibbons Lang & Company: Brown Gibbons Lang is a middle-market investment bank with deep industrial and consumer products coverage, frequently advising on technical product company transactions. It directly competes with Merrimack Group for sell-side mandates in its target verticals.
Broad incumbents
- Houlihan Lokey: Houlihan Lokey is a global investment bank with extensive middle-market M&A coverage across industrials and technology. As a broader incumbent with significantly more resources, it competes with Merrimack Group on larger mid-market technical product transactions where bulge-bracket-style execution is required.
- Robert W. Baird: Robert W. Baird's Global Investment Banking group covers middle-market industrials and technology M&A broadly. It is a broader incumbent peer that competes with Merrimack Group for sell-side mandates in industrial manufacturing and technical products.
Emerging players
- Generational Group: Generational Group is a middle-market M&A advisory firm focused on sell-side engagements for founder- and family-owned businesses, often in industrial and technical product sectors. It competes with Merrimack Group at the lower end of the $20M-$200M revenue range, particularly for smaller, owner-led transactions.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks4 records
Key highlights6 records
Customer concentration
Merrimack social profiles
Digital presenceMerrimack financial estimates
Financial estimateRevenue estimate
Valuation estimate
Merrimack leadership team
Management profileNumber of profiles
Profiles7 records
Merrimack funding detail
Funding detailFunding overview
Funding rounds15 records
Investors13 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Merrimack M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Merrimack
What does Merrimack do?
Merrimack Group is a specialist investment bank that provides sell-side mergers and acquisitions advisory services to founder-owned and privately held technical product companies. The firm manages the entire sale process from preparation through closing, including business positioning, buyer identification, competitive process management, and negotiation, targeting businesses with $20M-$200M in revenue. Merrimack has completed more than 30 transactions representing over $1 billion in aggregate enterprise value across lighting, aerospace & defense, electrical equipment, metal fabrication, industrial automation, and biotechnology sectors.
Is Merrimack a public or private company?
Merrimack is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Merrimack founded?
Merrimack was founded in 2000. It employs 51 to 100 people.
Where is Merrimack based?
Merrimack is headquartered in Cambridge, United States, in the North America region.
How does Merrimack make money?
One revenue line is on record: M&A Advisory Fees.
Who are Merrimack's main competitors?
Direct peers on record are Cascade Partners, TravisWolff, Lincoln International, Livingstone Partners, Cascadia Capital, PMCF (Plante Moran Corporate Finance) and Brown Gibbons Lang & Company. Broad incumbents are Houlihan Lokey and Robert W. Baird. Generational Group is listed as an emerging player.
Does Merrimack have an API?
No public API is recorded for Merrimack.